Lv71
4850 积分 2021-07-15 加入
Pathophysiology of Trousseau’s syndrome
14分钟前
已完结
Pathophysiology of Trousseau’s syndrome
15分钟前
已关闭
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
16天前
已完结
The impact of survivorship care on burden of disease among Hodgkin lymphoma survivors
25天前
已关闭
Positron Emission Tomography-Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial
25天前
已完结
Pembrolizumab-GVD in relapsed or refractory Hodgkin lymphoma: 5-year update of a multicenter phase 2 trial
26天前
已完结
Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma
26天前
已完结
Erratum: Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin Lymphoma
26天前
已关闭
Long-term Follow-up of Third-generation Anti-CD30 CAR T-cell Therapy in Relapsed/Refractory CD30+ Lymphomas: A Single-Arm, Multicenter, Phase I/II Trial
26天前
已完结
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study
26天前
已完结